Human Metabolome Technologies, Inc. (6090.T)

JPY 672.0

(-0.44%)

Operating Income Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual operating income in 2023 was 220.16 Million JPY , up 4.35% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly operating income in 2023 FY was 220.16 Million JPY , up 4.35% from previous quarter.
  • Human Metabolome Technologies, Inc. reported an annual operating income of 210.98 Million JPY in 2022, up 10.38% from previous year.
  • Human Metabolome Technologies, Inc. reported an annual operating income of 191.15 Million JPY in 2021, up 385.55% from previous year.
  • Human Metabolome Technologies, Inc. reported a quarterly operating income of 220.16 Million JPY for 2023 FY, up 4.35% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a quarterly operating income of -30.72 Million JPY for 2023 Q1, up 40.85% from previous quarter.

Annual Operating Income Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Operating Income of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 220.16 Million JPY 4.35%
2022 210.98 Million JPY 10.38%
2021 191.15 Million JPY 385.55%
2020 39.36 Million JPY 331.05%
2019 -17.03 Million JPY 0.0%

Peer Operating Income Comparison of Human Metabolome Technologies, Inc.

Name Operating Income Operating Income Difference
Shin Nippon Biomedical Laboratories, Ltd. 4.16 Billion JPY 94.71%
DNA Chip Research Inc. -258.21 Million JPY 185.265%
Cosmo Bio Company,Limited 519 Million JPY 57.578%
H.U. Group Holdings, Inc. -4.04 Billion JPY 105.446%
FALCO HOLDINGS Co., Ltd. 2.15 Billion JPY 89.769%
BML, Inc. 9.16 Billion JPY 97.599%
Precision System Science Co., Ltd. -956.24 Million JPY 123.024%